Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,470 | 4,186 | 2,389 | 5,088 | 5,571 |
| Depreciation Amortization | 1,084 | 728 | 370 | 1,525 | 1,142 |
| Accounts receivable | 835 | -1,176 | 119 | 611 | 811 |
| Other Working Capital | -1,780 | -2,448 | -652 | -2,058 | -1,764 |
| Other Operating Activity | -1,706 | 579 | -511 | -1,972 | -1,817 |
| Operating Cash Flow | $4,903 | $1,869 | $1,716 | $3,194 | $3,943 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -234 | -152 | -5 | -263 | -78 |
| Investing Cash Flow | $-234 | $-152 | $-5 | $-263 | $-78 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,014 | 1,014 |
| Debt Repayment | N/A | N/A | N/A | -105 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 42 | 42 |
| Other Financing Activity | -573 | -419 | -153 | -1,821 | -640 |
| Financing Cash Flow | $-573 | $-419 | $-153 | $-870 | $416 |
| Beginning Cash Position | 3,598 | 3,598 | 3,598 | 1,537 | 1,537 |
| End Cash Position | 7,694 | 4,896 | 5,156 | 3,598 | 5,818 |
| Net Cash Flow | $4,096 | $1,298 | $1,558 | $2,061 | $4,281 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,903 | 1,869 | 1,716 | 3,194 | 3,943 |
| Capital Expenditure | -234 | -152 | -5 | -330 | -145 |
| Free Cash Flow | 4,669 | 1,717 | 1,711 | 2,864 | 3,798 |